Related Experiment Videos
Fetal sacrococcygeal teratoma
Journal of Pediatric Surgery
|July 1, 1986
Summary
Fetal sacrococcygeal teratoma (SCT) diagnosis is increasing. Early hydrops or placentomegaly predicts demise, while later presentation after 30 weeks suggests better survival with planned cesarean delivery.
Area of Science:
- Perinatology
- Fetal Surgery
- Pediatric Oncology
Background:
- Sacrococcygeal teratoma (SCT) is increasingly diagnosed prenatally.
- Management strategies for fetal SCT require further understanding.
Observation:
- Most fetal SCT cases present between 22-34 weeks gestation.
- Uterine enlargement and polyhydramnios are common findings.
- Hydrops fetalis and placentomegaly are associated with poor outcomes.
Findings:
- The American Academy of Pediatrics Surgical Section classification does not predict fetal SCT outcomes.
- Late presentation (after 30 weeks) is a positive prognostic sign.
- Planned cesarean delivery can lead to fetal survival in later presentations.
- Hydrops/placentomegaly predict in utero demise (7/7 cases).
Implications:
- Prenatal diagnosis of SCT necessitates careful gestational age assessment for management.
- Identifying prognostic indicators like gestational age and hydrops is crucial for counseling and intervention.
- Further research into optimal delivery and surgical timing for fetal SCT is warranted.